We are live on ! Find out more
HTGM

HTG Molecular Diagnostics, Inc. Common Stock
HTGM

Delisted

HTGM was delisted on the 14th of June, 2023.

Back to rankings

10 hedge funds and large institutions have $66.2K invested in HTG Molecular Diagnostics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% less funds holding

Funds holding: 18 → 10 (-8)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

77% less capital invested

Capital invested by funds: $283K → $66.2K (-$217K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 8

Holders
10
Holders Change
-8
Holders Change %
-44.44%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
4
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$38.6K
2
UBS Group
UBS Group
Switzerland
+$12.1K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$53K
2
VF
Virtu Financial
New York
-$44K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$43K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$28K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$17K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
1
Tower Research Capital (TRC)
New York
$27K +$38.6K +6,313 +1,679%
BlackRock
2
BlackRock
New York
$24.4K -$483 -79 -1%
UBS Group
3
UBS Group
Switzerland
$7.88K +$12.1K +1,973 +98,650%
Morgan Stanley
4
Morgan Stanley
New York
$3.53K – – –
HWM
5
HighMark Wealth Management
Minnesota
$2.31K -$6 -1 -0.2%
AF
6
Allworth Financial
California
$1.1K – – –
Wells Fargo
7
Wells Fargo
California
$16 – – –
TWA
8
TCI Wealth Advisors
Arizona
$8 – – –
Renaissance Technologies
9
Renaissance Technologies
New York
– -$53K -7,200 Closed
VF
10
Virtu Financial
New York
– -$44K -6,038 Closed
Vanguard Group
11
Vanguard Group
Pennsylvania
– -$43K -5,910 Closed
Geode Capital Management
12
Geode Capital Management
Massachusetts
– -$28K -3,932 Closed
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
– -$17K -2,288 Closed
Millennium Management
14
Millennium Management
New York
– -$15K -1,974 Closed
TSS
15
Two Sigma Securities
New York
– -$13K -1,806 Closed
State Street
16
State Street
Massachusetts
– -$9K -1,205 Closed
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
– -$24 -4 -50%
JP Morgan Chase
18
JP Morgan Chase
New York
– -$6 -1 -50%

HTGM Hedge Fund Activity: Q4 2022 in Review

10 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in HTG Molecular Diagnostics, Inc. Common Stock (HTGM) for Q4 2022, worth a combined $66.2K — down 77% from $283K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of HTGM and 0 opened new positions — a net loss of 8 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $38.6K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $53K sold.

  • 10 institutional investors held HTG Molecular Diagnostics, Inc. Common Stock (HTGM) as of Q4 2022, down from 18 in Q3 2022.
  • Funds reported $66.2K of HTG Molecular Diagnostics, Inc. Common Stock stock for Q4 2022, down 77% quarter-over-quarter.
  • 0 funds opened new HTG Molecular Diagnostics, Inc. Common Stock positions in Q4 2022 and 8 closed out, a net change of -8 holders.
  • The largest HTG Molecular Diagnostics, Inc. Common Stock buyer in Q4 2022 was Tower Research Capital (TRC), an estimated $38.6K added.
  • The largest HTG Molecular Diagnostics, Inc. Common Stock seller in Q4 2022 was Renaissance Technologies, an estimated $53K sold.

Based on aggregated 13F filings for Q4 2022.